Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs RingCentral Inc. Class A Common Stock (RNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs RingCentral Inc. Class A Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.59 (market cap $6.04B), while RingCentral Inc. Class A Common Stock trades at $79.35 (market cap $6.54B). The key difference: Iovance Biotherapeutics Inc. Common Stock and RingCentral Inc. Class A Common Stock are close in size by market cap, and RingCentral Inc. Class A Common Stock pays a 0.35% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and RingCentral Inc. Class A Common Stock for 0 Days on average.
| IOVA | RNG | |
|---|---|---|
Market Cap | $6.04B | $6.54B |
Volume | 14,805,993 | 1,543,570 |
Sector | Health | Technology |
52-Week High | $14.82 | $79.82 |
52-Week Low | $1.81 | $24.82 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.97B | $7.60B |
Dividend Yield | — | 0.35% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About RingCentral Inc. Class A Common Stock
RingCentral provides cloud-based business communications and contact center solutions. Its platform combines phone, messaging, video meetings, and customer-service tools.
Read more on RNG →
